This Article Full Text Full Text (PDF) Supplementary Data All Versions of this Article: 0008-5472.CAN-08-4400v1 69/20/8120    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Britton, S. Articles by Calsou, P. PubMed PubMed Citation Articles by Britton, S. Articles by Calsou, P.

ARTEMIS Nuclease Facilitates Apoptotic Chromatin Cleavage

¹ CNRS, Institut de Pharmacologie et de Biologie Structurale; ² Université de Toulouse, UPS, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France and ³ CEA-DSV-iRCM/INSERM U935, Institut A. Lwoff-CNRS, Villejuif, France

Requests for reprints: Bernard Salles, Institut de Pharmacologie et de Biologie Structurale, 205 route de Narbonne, 31077 Toulouse cedex, France. Phone: 33-5-61-17-59-36; Fax: 33-5-61-17-59-33; E-mail: bernard.salles{at}ipbs.fr.

Key Words: apoptosis • DNA fragmentation • ARTEMIS • DNA-PK • nuclear matrix • MLL gene

One hallmark of apoptosis is DNA degradation that first appears as high molecular weight fragments followed by extensive internucleosomal fragmentation. During apoptosis, the DNA-dependent protein kinase (DNA-PK) is activated. DNA-PK is involved in the repair of DNA double-strand breaks (DSB) and its catalytic subunit is associated with the nuclease ARTEMIS. Here, we report that, on initiation of apoptosis in human cells by agents causing DNA DSB or by staurosporine or other agents, ARTEMIS binds to apoptotic chromatin together with DNA-PK and other DSB repair proteins. ARTEMIS recruitment to chromatin showed a time and dose dependency. It required DNA-PK protein kinase activity and was blocked by antagonizing the onset of apoptosis with a pan-caspase inhibitor or on overexpression of the antiapoptotic BCL2 protein. In the absence of ARTEMIS, no defect in caspase-3, poly(ADP-ribose) polymerase-1, and XRCC4 cleavage or in H2AX phosphorylation was observed and DNA-PK catalytic subunit was still phosphorylated on S2056 in response to staurosporine. However, DNA fragmentation including high molecular weight fragmentation was delayed in ARTEMIS-deficient cells compared with cells expressing ARTEMIS. In addition, ARTEMIS enhanced the kinetics of MLL gene cleavage at a breakage cluster breakpoint that is frequently translocated in acute or therapy-related leukemias. These results show a facilitating role for ARTEMIS at least in early, site-specific chromosome breakage during apoptosis. [Cancer Res 2009;69(20):8120–6]